Biolase Inc. (BIOL) Enterprise Value to EBITDA Ratio
This BIOLASE, Inc. (BIOL) chart on GURU.Markets, where EV/EBITDA stands at , demonstrates the dental laser manufacturer's struggle for clinic budgets amid pressure from traditional methods. The business is suffering from operating losses, component shortages, and slow adoption of innovations by practitioners. Meanwhile, a stable cash flow is maintained through the servicing of previously sold systems and the sale of replacement nozzles.
Comprehensive metric breakdowns and analytics for biolase.com (BIOL)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
BIOL - Net Financial Result|Projected Future Earnings BIOLASE, Inc.|BIOL - Price to Earnings Ratio|Forward P/E Multiple BIOLASE, Inc.|BIOL - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biolase Inc.|BIOL - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months BIOLASE|BIOL - Earnings per share for the trailing year|Quarterly EPS earnings growth biolase.com|BIOL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year BIOLASE, Inc.
Analysis of all company metrics:Biolase, Inc. BIOL
The multiple compares the total enterprise value, including net debt, with operating profit before taxes and amortization to determine the asset's real value. By analyzing the EV/EBITDA value of the company on the chart, an investor identifies whether the business is overbought or undervalued relative to its ability to generate cash flow. For BIOLASE, Inc. (BIOL), this metric reflects the efficiency of capital investments in robotic laser systems that automate microsurgery in dentistry.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|TNON: EV/EBITDA Multiple|LFWD (rewalk.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AMIX (Autonomix Medical Inc.) - EV/EBITDA Multiple|INVO Bioscience (IVF) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bone Biologics Corporation (BBLG)|AXNX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|Paragon 28 Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|INVO Bio - EV/EBITDA Multiple
